Patients’ perspectives after switching from infliximab to biosimilar CT-P13 in patients with inflammatory bowel disease: A 12-month prospective cohort study
Patients’ perspectives after switching from infliximab to a biosimilar have yet to be assessed.
Autor*in: |
Petitdidier, Nicolas [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2019 |
---|
Schlagwörter: |
---|
Umfang: |
9 |
---|
Übergeordnetes Werk: |
Enthalten in: The relationship between physical performance and cardiac function in an elderly Russian cohort - Tadjibaev, Pulod ELSEVIER, 2014, official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, [S.l.] |
---|---|
Übergeordnetes Werk: |
volume:51 ; year:2019 ; number:12 ; pages:1652-1660 ; extent:9 |
Links: |
---|
DOI / URN: |
10.1016/j.dld.2019.08.020 |
---|
Katalog-ID: |
ELV048583448 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV048583448 | ||
003 | DE-627 | ||
005 | 20230624145144.0 | ||
007 | cr uuu---uuuuu | ||
008 | 200108s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.dld.2019.08.020 |2 doi | |
028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001781.pica |
035 | |a (DE-627)ELV048583448 | ||
035 | |a (ELSEVIER)S1590-8658(19)30783-2 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q VZ |
082 | 0 | 4 | |a 630 |a 640 |a 610 |q VZ |
100 | 1 | |a Petitdidier, Nicolas |e verfasserin |4 aut | |
245 | 1 | 0 | |a Patients’ perspectives after switching from infliximab to biosimilar CT-P13 in patients with inflammatory bowel disease: A 12-month prospective cohort study |
264 | 1 | |c 2019 | |
300 | |a 9 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a Patients’ perspectives after switching from infliximab to a biosimilar have yet to be assessed. | ||
650 | 7 | |a Inflammatory bowel disease |2 Elsevier | |
650 | 7 | |a Infliximab |2 Elsevier | |
650 | 7 | |a CT-P13 |2 Elsevier | |
650 | 7 | |a Biosimilar |2 Elsevier | |
650 | 7 | |a Crohn’s disease |2 Elsevier | |
650 | 7 | |a Ulcerative colitis |2 Elsevier | |
700 | 1 | |a Tannoury, Jenny |4 oth | |
700 | 1 | |a de’Angelis, Nicola |4 oth | |
700 | 1 | |a Gagniere, Charlotte |4 oth | |
700 | 1 | |a Hulin, Anne |4 oth | |
700 | 1 | |a Rotkopf, Hugo |4 oth | |
700 | 1 | |a Mesli, Farida |4 oth | |
700 | 1 | |a Brunetti, Francesco |4 oth | |
700 | 1 | |a Sobhani, Iradj |4 oth | |
700 | 1 | |a Amiot, Aurelien |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Saunders |a Tadjibaev, Pulod ELSEVIER |t The relationship between physical performance and cardiac function in an elderly Russian cohort |d 2014 |d official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver |g [S.l.] |w (DE-627)ELV012117463 |
773 | 1 | 8 | |g volume:51 |g year:2019 |g number:12 |g pages:1652-1660 |g extent:9 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.dld.2019.08.020 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_105 | ||
951 | |a AR | ||
952 | |d 51 |j 2019 |e 12 |h 1652-1660 |g 9 |
author_variant |
n p np |
---|---|
matchkey_str |
petitdidiernicolastannouryjennydeangelis:2019----:ainsesetvsfesicigrmnlxmboismlrt1iptetwtifamtrbwli |
hierarchy_sort_str |
2019 |
publishDate |
2019 |
allfields |
10.1016/j.dld.2019.08.020 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001781.pica (DE-627)ELV048583448 (ELSEVIER)S1590-8658(19)30783-2 DE-627 ger DE-627 rakwb eng 610 VZ 630 640 610 VZ Petitdidier, Nicolas verfasserin aut Patients’ perspectives after switching from infliximab to biosimilar CT-P13 in patients with inflammatory bowel disease: A 12-month prospective cohort study 2019 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Patients’ perspectives after switching from infliximab to a biosimilar have yet to be assessed. Inflammatory bowel disease Elsevier Infliximab Elsevier CT-P13 Elsevier Biosimilar Elsevier Crohn’s disease Elsevier Ulcerative colitis Elsevier Tannoury, Jenny oth de’Angelis, Nicola oth Gagniere, Charlotte oth Hulin, Anne oth Rotkopf, Hugo oth Mesli, Farida oth Brunetti, Francesco oth Sobhani, Iradj oth Amiot, Aurelien oth Enthalten in Saunders Tadjibaev, Pulod ELSEVIER The relationship between physical performance and cardiac function in an elderly Russian cohort 2014 official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [S.l.] (DE-627)ELV012117463 volume:51 year:2019 number:12 pages:1652-1660 extent:9 https://doi.org/10.1016/j.dld.2019.08.020 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_22 GBV_ILN_40 GBV_ILN_105 AR 51 2019 12 1652-1660 9 |
spelling |
10.1016/j.dld.2019.08.020 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001781.pica (DE-627)ELV048583448 (ELSEVIER)S1590-8658(19)30783-2 DE-627 ger DE-627 rakwb eng 610 VZ 630 640 610 VZ Petitdidier, Nicolas verfasserin aut Patients’ perspectives after switching from infliximab to biosimilar CT-P13 in patients with inflammatory bowel disease: A 12-month prospective cohort study 2019 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Patients’ perspectives after switching from infliximab to a biosimilar have yet to be assessed. Inflammatory bowel disease Elsevier Infliximab Elsevier CT-P13 Elsevier Biosimilar Elsevier Crohn’s disease Elsevier Ulcerative colitis Elsevier Tannoury, Jenny oth de’Angelis, Nicola oth Gagniere, Charlotte oth Hulin, Anne oth Rotkopf, Hugo oth Mesli, Farida oth Brunetti, Francesco oth Sobhani, Iradj oth Amiot, Aurelien oth Enthalten in Saunders Tadjibaev, Pulod ELSEVIER The relationship between physical performance and cardiac function in an elderly Russian cohort 2014 official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [S.l.] (DE-627)ELV012117463 volume:51 year:2019 number:12 pages:1652-1660 extent:9 https://doi.org/10.1016/j.dld.2019.08.020 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_22 GBV_ILN_40 GBV_ILN_105 AR 51 2019 12 1652-1660 9 |
allfields_unstemmed |
10.1016/j.dld.2019.08.020 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001781.pica (DE-627)ELV048583448 (ELSEVIER)S1590-8658(19)30783-2 DE-627 ger DE-627 rakwb eng 610 VZ 630 640 610 VZ Petitdidier, Nicolas verfasserin aut Patients’ perspectives after switching from infliximab to biosimilar CT-P13 in patients with inflammatory bowel disease: A 12-month prospective cohort study 2019 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Patients’ perspectives after switching from infliximab to a biosimilar have yet to be assessed. Inflammatory bowel disease Elsevier Infliximab Elsevier CT-P13 Elsevier Biosimilar Elsevier Crohn’s disease Elsevier Ulcerative colitis Elsevier Tannoury, Jenny oth de’Angelis, Nicola oth Gagniere, Charlotte oth Hulin, Anne oth Rotkopf, Hugo oth Mesli, Farida oth Brunetti, Francesco oth Sobhani, Iradj oth Amiot, Aurelien oth Enthalten in Saunders Tadjibaev, Pulod ELSEVIER The relationship between physical performance and cardiac function in an elderly Russian cohort 2014 official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [S.l.] (DE-627)ELV012117463 volume:51 year:2019 number:12 pages:1652-1660 extent:9 https://doi.org/10.1016/j.dld.2019.08.020 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_22 GBV_ILN_40 GBV_ILN_105 AR 51 2019 12 1652-1660 9 |
allfieldsGer |
10.1016/j.dld.2019.08.020 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001781.pica (DE-627)ELV048583448 (ELSEVIER)S1590-8658(19)30783-2 DE-627 ger DE-627 rakwb eng 610 VZ 630 640 610 VZ Petitdidier, Nicolas verfasserin aut Patients’ perspectives after switching from infliximab to biosimilar CT-P13 in patients with inflammatory bowel disease: A 12-month prospective cohort study 2019 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Patients’ perspectives after switching from infliximab to a biosimilar have yet to be assessed. Inflammatory bowel disease Elsevier Infliximab Elsevier CT-P13 Elsevier Biosimilar Elsevier Crohn’s disease Elsevier Ulcerative colitis Elsevier Tannoury, Jenny oth de’Angelis, Nicola oth Gagniere, Charlotte oth Hulin, Anne oth Rotkopf, Hugo oth Mesli, Farida oth Brunetti, Francesco oth Sobhani, Iradj oth Amiot, Aurelien oth Enthalten in Saunders Tadjibaev, Pulod ELSEVIER The relationship between physical performance and cardiac function in an elderly Russian cohort 2014 official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [S.l.] (DE-627)ELV012117463 volume:51 year:2019 number:12 pages:1652-1660 extent:9 https://doi.org/10.1016/j.dld.2019.08.020 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_22 GBV_ILN_40 GBV_ILN_105 AR 51 2019 12 1652-1660 9 |
allfieldsSound |
10.1016/j.dld.2019.08.020 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001781.pica (DE-627)ELV048583448 (ELSEVIER)S1590-8658(19)30783-2 DE-627 ger DE-627 rakwb eng 610 VZ 630 640 610 VZ Petitdidier, Nicolas verfasserin aut Patients’ perspectives after switching from infliximab to biosimilar CT-P13 in patients with inflammatory bowel disease: A 12-month prospective cohort study 2019 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Patients’ perspectives after switching from infliximab to a biosimilar have yet to be assessed. Inflammatory bowel disease Elsevier Infliximab Elsevier CT-P13 Elsevier Biosimilar Elsevier Crohn’s disease Elsevier Ulcerative colitis Elsevier Tannoury, Jenny oth de’Angelis, Nicola oth Gagniere, Charlotte oth Hulin, Anne oth Rotkopf, Hugo oth Mesli, Farida oth Brunetti, Francesco oth Sobhani, Iradj oth Amiot, Aurelien oth Enthalten in Saunders Tadjibaev, Pulod ELSEVIER The relationship between physical performance and cardiac function in an elderly Russian cohort 2014 official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [S.l.] (DE-627)ELV012117463 volume:51 year:2019 number:12 pages:1652-1660 extent:9 https://doi.org/10.1016/j.dld.2019.08.020 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_22 GBV_ILN_40 GBV_ILN_105 AR 51 2019 12 1652-1660 9 |
language |
English |
source |
Enthalten in The relationship between physical performance and cardiac function in an elderly Russian cohort [S.l.] volume:51 year:2019 number:12 pages:1652-1660 extent:9 |
sourceStr |
Enthalten in The relationship between physical performance and cardiac function in an elderly Russian cohort [S.l.] volume:51 year:2019 number:12 pages:1652-1660 extent:9 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
Inflammatory bowel disease Infliximab CT-P13 Biosimilar Crohn’s disease Ulcerative colitis |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
The relationship between physical performance and cardiac function in an elderly Russian cohort |
authorswithroles_txt_mv |
Petitdidier, Nicolas @@aut@@ Tannoury, Jenny @@oth@@ de’Angelis, Nicola @@oth@@ Gagniere, Charlotte @@oth@@ Hulin, Anne @@oth@@ Rotkopf, Hugo @@oth@@ Mesli, Farida @@oth@@ Brunetti, Francesco @@oth@@ Sobhani, Iradj @@oth@@ Amiot, Aurelien @@oth@@ |
publishDateDaySort_date |
2019-01-01T00:00:00Z |
hierarchy_top_id |
ELV012117463 |
dewey-sort |
3610 |
id |
ELV048583448 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV048583448</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624145144.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">200108s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.dld.2019.08.020</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001781.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV048583448</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1590-8658(19)30783-2</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">630</subfield><subfield code="a">640</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Petitdidier, Nicolas</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Patients’ perspectives after switching from infliximab to biosimilar CT-P13 in patients with inflammatory bowel disease: A 12-month prospective cohort study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Patients’ perspectives after switching from infliximab to a biosimilar have yet to be assessed.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Inflammatory bowel disease</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Infliximab</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CT-P13</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Biosimilar</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Crohn’s disease</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ulcerative colitis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tannoury, Jenny</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">de’Angelis, Nicola</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gagniere, Charlotte</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hulin, Anne</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rotkopf, Hugo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mesli, Farida</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brunetti, Francesco</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sobhani, Iradj</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Amiot, Aurelien</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Saunders</subfield><subfield code="a">Tadjibaev, Pulod ELSEVIER</subfield><subfield code="t">The relationship between physical performance and cardiac function in an elderly Russian cohort</subfield><subfield code="d">2014</subfield><subfield code="d">official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver</subfield><subfield code="g">[S.l.]</subfield><subfield code="w">(DE-627)ELV012117463</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:51</subfield><subfield code="g">year:2019</subfield><subfield code="g">number:12</subfield><subfield code="g">pages:1652-1660</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.dld.2019.08.020</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">51</subfield><subfield code="j">2019</subfield><subfield code="e">12</subfield><subfield code="h">1652-1660</subfield><subfield code="g">9</subfield></datafield></record></collection>
|
author |
Petitdidier, Nicolas |
spellingShingle |
Petitdidier, Nicolas ddc 610 ddc 630 Elsevier Inflammatory bowel disease Elsevier Infliximab Elsevier CT-P13 Elsevier Biosimilar Elsevier Crohn’s disease Elsevier Ulcerative colitis Patients’ perspectives after switching from infliximab to biosimilar CT-P13 in patients with inflammatory bowel disease: A 12-month prospective cohort study |
authorStr |
Petitdidier, Nicolas |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV012117463 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health 630 - Agriculture & related technologies 640 - Home & family management |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 VZ 630 640 610 VZ Patients’ perspectives after switching from infliximab to biosimilar CT-P13 in patients with inflammatory bowel disease: A 12-month prospective cohort study Inflammatory bowel disease Elsevier Infliximab Elsevier CT-P13 Elsevier Biosimilar Elsevier Crohn’s disease Elsevier Ulcerative colitis Elsevier |
topic |
ddc 610 ddc 630 Elsevier Inflammatory bowel disease Elsevier Infliximab Elsevier CT-P13 Elsevier Biosimilar Elsevier Crohn’s disease Elsevier Ulcerative colitis |
topic_unstemmed |
ddc 610 ddc 630 Elsevier Inflammatory bowel disease Elsevier Infliximab Elsevier CT-P13 Elsevier Biosimilar Elsevier Crohn’s disease Elsevier Ulcerative colitis |
topic_browse |
ddc 610 ddc 630 Elsevier Inflammatory bowel disease Elsevier Infliximab Elsevier CT-P13 Elsevier Biosimilar Elsevier Crohn’s disease Elsevier Ulcerative colitis |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
j t jt n d nd c g cg a h ah h r hr f m fm f b fb i s is a a aa |
hierarchy_parent_title |
The relationship between physical performance and cardiac function in an elderly Russian cohort |
hierarchy_parent_id |
ELV012117463 |
dewey-tens |
610 - Medicine & health 630 - Agriculture 640 - Home & family management |
hierarchy_top_title |
The relationship between physical performance and cardiac function in an elderly Russian cohort |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV012117463 |
title |
Patients’ perspectives after switching from infliximab to biosimilar CT-P13 in patients with inflammatory bowel disease: A 12-month prospective cohort study |
ctrlnum |
(DE-627)ELV048583448 (ELSEVIER)S1590-8658(19)30783-2 |
title_full |
Patients’ perspectives after switching from infliximab to biosimilar CT-P13 in patients with inflammatory bowel disease: A 12-month prospective cohort study |
author_sort |
Petitdidier, Nicolas |
journal |
The relationship between physical performance and cardiac function in an elderly Russian cohort |
journalStr |
The relationship between physical performance and cardiac function in an elderly Russian cohort |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology |
recordtype |
marc |
publishDateSort |
2019 |
contenttype_str_mv |
zzz |
container_start_page |
1652 |
author_browse |
Petitdidier, Nicolas |
container_volume |
51 |
physical |
9 |
class |
610 VZ 630 640 610 VZ |
format_se |
Elektronische Aufsätze |
author-letter |
Petitdidier, Nicolas |
doi_str_mv |
10.1016/j.dld.2019.08.020 |
dewey-full |
610 630 640 |
title_sort |
patients’ perspectives after switching from infliximab to biosimilar ct-p13 in patients with inflammatory bowel disease: a 12-month prospective cohort study |
title_auth |
Patients’ perspectives after switching from infliximab to biosimilar CT-P13 in patients with inflammatory bowel disease: A 12-month prospective cohort study |
abstract |
Patients’ perspectives after switching from infliximab to a biosimilar have yet to be assessed. |
abstractGer |
Patients’ perspectives after switching from infliximab to a biosimilar have yet to be assessed. |
abstract_unstemmed |
Patients’ perspectives after switching from infliximab to a biosimilar have yet to be assessed. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_22 GBV_ILN_40 GBV_ILN_105 |
container_issue |
12 |
title_short |
Patients’ perspectives after switching from infliximab to biosimilar CT-P13 in patients with inflammatory bowel disease: A 12-month prospective cohort study |
url |
https://doi.org/10.1016/j.dld.2019.08.020 |
remote_bool |
true |
author2 |
Tannoury, Jenny de’Angelis, Nicola Gagniere, Charlotte Hulin, Anne Rotkopf, Hugo Mesli, Farida Brunetti, Francesco Sobhani, Iradj Amiot, Aurelien |
author2Str |
Tannoury, Jenny de’Angelis, Nicola Gagniere, Charlotte Hulin, Anne Rotkopf, Hugo Mesli, Farida Brunetti, Francesco Sobhani, Iradj Amiot, Aurelien |
ppnlink |
ELV012117463 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth oth oth oth oth oth |
doi_str |
10.1016/j.dld.2019.08.020 |
up_date |
2024-07-06T19:14:25.253Z |
_version_ |
1803858230906978304 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV048583448</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624145144.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">200108s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.dld.2019.08.020</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001781.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV048583448</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1590-8658(19)30783-2</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">630</subfield><subfield code="a">640</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Petitdidier, Nicolas</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Patients’ perspectives after switching from infliximab to biosimilar CT-P13 in patients with inflammatory bowel disease: A 12-month prospective cohort study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Patients’ perspectives after switching from infliximab to a biosimilar have yet to be assessed.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Inflammatory bowel disease</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Infliximab</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CT-P13</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Biosimilar</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Crohn’s disease</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ulcerative colitis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tannoury, Jenny</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">de’Angelis, Nicola</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gagniere, Charlotte</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hulin, Anne</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rotkopf, Hugo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mesli, Farida</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brunetti, Francesco</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sobhani, Iradj</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Amiot, Aurelien</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Saunders</subfield><subfield code="a">Tadjibaev, Pulod ELSEVIER</subfield><subfield code="t">The relationship between physical performance and cardiac function in an elderly Russian cohort</subfield><subfield code="d">2014</subfield><subfield code="d">official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver</subfield><subfield code="g">[S.l.]</subfield><subfield code="w">(DE-627)ELV012117463</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:51</subfield><subfield code="g">year:2019</subfield><subfield code="g">number:12</subfield><subfield code="g">pages:1652-1660</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.dld.2019.08.020</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">51</subfield><subfield code="j">2019</subfield><subfield code="e">12</subfield><subfield code="h">1652-1660</subfield><subfield code="g">9</subfield></datafield></record></collection>
|
score |
7.398551 |